{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:58:46Z","timestamp":1786467526615,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jaip.2018.06.017","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T16:15:24Z","timestamp":1530980124000},"page":"1746-1748.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["A case of chronic eosinophilic pneumonia successfully treated with mepolizumab"],"prefix":"10.1016","volume":"6","author":[{"given":"Masako","family":"To","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yamawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiko","family":"Soeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otohiro","family":"Katsube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2018.06.017_bib1","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jaip.2018.03.011","article-title":"Eosinophilic pneumonias","volume":"6","author":"Allen","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.06.017_bib2","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.2169\/internalmedicine.55.6765","article-title":"The long-term clinical course of chronic eosinophilic pneumonia","volume":"55","author":"Ishiguro","year":"2016","journal-title":"Intern Med"},{"key":"10.1016\/j.jaip.2018.06.017_bib3","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1183\/09031936.00199614","article-title":"Efficacy of short-term prednisolone treatment in patients with chronic eosinophilic pneumonia","volume":"45","author":"Oyama","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2018.06.017_bib4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.alit.2017.12.004","article-title":"Long-term management and persistent impairment of pulmonary function in chronic eosinophilic pneumonia: a review of the previous literature","volume":"67","author":"Suzuki","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2018.06.017_bib5","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1164\/ajrccm.153.4.8616578","article-title":"Cytokine production at the site of disease in chronic eosinophilic pneumonitis","volume":"153","author":"Kita","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2018.06.017_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3960\/jslrt.55.97","article-title":"Marked thrombocytosis in chronic eosinophilic pneumonia and analysis of cytokine mechanism","volume":"55","author":"Nishimori","year":"2015","journal-title":"J\u00a0Clin Exp Hematop"},{"key":"10.1016\/j.jaip.2018.06.017_bib7","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1183\/09031936.01.17509620","article-title":"Eotaxin and monocyte chemoattractant protein-1 in chronic eosinophilic pneumonia","volume":"17","author":"Tateno","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2018.06.017_bib8","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2018.06.017_bib9","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.clinthera.2016.07.010","article-title":"Long-term efficacy and safety of mepolizumab in patients with severe eosinophilic asthma: a multi-center, open-label, phase IIIb study","volume":"38","author":"Lugogo","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaip.2018.06.017_bib10","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jaip.2017.11.026","article-title":"Evaluation of potential continuation rules for mepolizumab treatment of severe eosinophilic asthma","volume":"6","author":"Gunsoy","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818304185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818304185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:17:28Z","timestamp":1761974248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219818304185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S2213219818304185"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2018.06.017","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of chronic eosinophilic pneumonia successfully treated with mepolizumab","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2018.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}